FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2029883937> ?p ?o ?g. }

• W2029883937 endingPage "209" @default.
• W2029883937 startingPage "209" @default.
• W2029883937 abstract "To compare the efficacy and tolerability of a fixed-dose combination of 0.3% gatifloxacin and 1% prednisolone formulation versus the same agents administered separately for prophylaxis in a laser-assisted in situ keratomileusis (LASIK) population.In a prospective, randomized, double-masked, parallel-group study, 97 patients were evaluated for signs and symptoms of ocular infection or inflammation after bilateral LASIK. Group 1 (50 patients, 100 eyes) received a combined formulation of 0.3% gatifloxacin + 1% prednisolone acetate (Zypred(®)) plus placebo. Group 2 (47 patients, 94 eyes) received conventional treatment with the same agents from separate vials. The cohorts were similar in age, sex, race, and refractive error. Baseline and postoperative assessments were made on surgery days -2, 1, 3, and 15 and consisted of visual acuity; intraocular pressure; severity of inflammation of eyelids, conjunctiva, and cornea; tearing; ocular discomfort (foreign-body sensation, itching, or photophobia); and ocular pain. The posterior segment was evaluated at the screening and exit visits.No ocular infection or persistent inflammation was detected in either group at any time. All objective and subjective criteria of efficacy were similar regardless of treatment, with no significant differences between the groups. More patients who were dosed with the combined agent complained of mild ocular discomfort on day 3, but this difference had disappeared by day 15.Post-LASIK topical prophylaxis with combined gatifloxacin + prednisolone eye drops (Zypred(®)) was well tolerated. This formulation appears to be therapeutically equivalent to conventional dosing with gatifloxacin and prednisolone from individual bottles for topical prophylaxis after laser refractive surgery." @default.
• W2029883937 created "2016-06-24" @default.
• W2029883937 creator A5020015571 @default.
• W2029883937 creator A5021667047 @default.
• W2029883937 creator A5060468410 @default.
• W2029883937 creator A5062429705 @default.
• W2029883937 creator A5076181472 @default.
• W2029883937 creator A5079948264 @default.
• W2029883937 date "2011-02-01" @default.
• W2029883937 modified "2023-09-30" @default.
• W2029883937 title "Efficacy and tolerability of a combined gatifloxacin plus prednisolone formulation for topical prophylaxis after LASIK" @default.
• W2029883937 cites W133793591 @default.
• W2029883937 cites W151436713 @default.
• W2029883937 cites W152586991 @default.
• W2029883937 cites W1537939696 @default.
• W2029883937 cites W1552454559 @default.
• W2029883937 cites W1959546483 @default.
• W2029883937 cites W1971706578 @default.
• W2029883937 cites W1972281101 @default.
• W2029883937 cites W1979423522 @default.
• W2029883937 cites W1985166893 @default.
• W2029883937 cites W1988571323 @default.
• W2029883937 cites W1989999031 @default.
• W2029883937 cites W1990618253 @default.
• W2029883937 cites W1992723025 @default.
• W2029883937 cites W2002020920 @default.
• W2029883937 cites W2012972896 @default.
• W2029883937 cites W2033354125 @default.
• W2029883937 cites W2038456960 @default.
• W2029883937 cites W2039379057 @default.
• W2029883937 cites W2040894068 @default.
• W2029883937 cites W2045922182 @default.
• W2029883937 cites W2054290562 @default.
• W2029883937 cites W2060113182 @default.
• W2029883937 cites W2067852897 @default.
• W2029883937 cites W2069894300 @default.
• W2029883937 cites W2071335655 @default.
• W2029883937 cites W2074490875 @default.
• W2029883937 cites W2078568754 @default.
• W2029883937 cites W2078894935 @default.
• W2029883937 cites W2086902602 @default.
• W2029883937 cites W2092698254 @default.
• W2029883937 cites W2112381450 @default.
• W2029883937 cites W2147795522 @default.
• W2029883937 cites W2153959357 @default.
• W2029883937 cites W2159985229 @default.
• W2029883937 cites W2403157244 @default.
• W2029883937 cites W2430272697 @default.
• W2029883937 cites W2462617095 @default.
• W2029883937 cites W55719170 @default.
• W2029883937 cites W69122850 @default.
• W2029883937 cites W2842556333 @default.
• W2029883937 doi "https://doi.org/10.2147/opth.s17059" @default.
• W2029883937 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3046990" @default.
• W2029883937 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21386913" @default.
• W2029883937 hasPublicationYear "2011" @default.
• W2029883937 type Work @default.
• W2029883937 sameAs 2029883937 @default.
• W2029883937 citedByCount "4" @default.
• W2029883937 countsByYear W20298839372013 @default.
• W2029883937 countsByYear W20298839372015 @default.
• W2029883937 countsByYear W20298839372021 @default.
• W2029883937 crossrefType "journal-article" @default.
• W2029883937 hasAuthorship W2029883937A5020015571 @default.
• W2029883937 hasAuthorship W2029883937A5021667047 @default.
• W2029883937 hasAuthorship W2029883937A5060468410 @default.
• W2029883937 hasAuthorship W2029883937A5062429705 @default.
• W2029883937 hasAuthorship W2029883937A5076181472 @default.
• W2029883937 hasAuthorship W2029883937A5079948264 @default.
• W2029883937 hasBestOaLocation W20298839371 @default.
• W2029883937 hasConcept C118487528 @default.
• W2029883937 hasConcept C126322002 @default.
• W2029883937 hasConcept C141071460 @default.
• W2029883937 hasConcept C142724271 @default.
• W2029883937 hasConcept C197934379 @default.
• W2029883937 hasConcept C204787440 @default.
• W2029883937 hasConcept C27081682 @default.
• W2029883937 hasConcept C2776715498 @default.
• W2029883937 hasConcept C2777653605 @default.
• W2029883937 hasConcept C2778375690 @default.
• W2029883937 hasConcept C2778512257 @default.
• W2029883937 hasConcept C2780350528 @default.
• W2029883937 hasConcept C2780590625 @default.
• W2029883937 hasConcept C2781092963 @default.
• W2029883937 hasConcept C42219234 @default.
• W2029883937 hasConcept C523546767 @default.
• W2029883937 hasConcept C54355233 @default.
• W2029883937 hasConcept C71924100 @default.
• W2029883937 hasConcept C86803240 @default.
• W2029883937 hasConceptScore W2029883937C118487528 @default.
• W2029883937 hasConceptScore W2029883937C126322002 @default.
• W2029883937 hasConceptScore W2029883937C141071460 @default.
• W2029883937 hasConceptScore W2029883937C142724271 @default.
• W2029883937 hasConceptScore W2029883937C197934379 @default.
• W2029883937 hasConceptScore W2029883937C204787440 @default.
• W2029883937 hasConceptScore W2029883937C27081682 @default.
• W2029883937 hasConceptScore W2029883937C2776715498 @default.
• W2029883937 hasConceptScore W2029883937C2777653605 @default.

• next